The global irritable bowel syndrome treatment market is estimated to be valued at US$ 1,444.7 million in 2022 and is expected to exhibit a CAGR of 13.2% during the forecast period (2022-2030).
Growing prevalence of irritable bowel syndrome as well as impact of dietary factors on gut health are expected to drive growth of the global irritable bowel syndrome treatment market.
The increasing prevalence of irritable bowel syndrome (IBS) is expected to drive the market growth over the forecast period. For instance, according to an article published by Cureus, an open access general medical journal, in January 2021, a cross-section study was conducted in the internal medicine unit of a tertiary care hospital in multiple cities of Pakistan from June 2019 to August 2019, to find out the prevalence of IBS in healthy population and determine the characteristics of symptoms. According to the results, the prevalence of IBS in general population was 33.2%.
Irritable Bowel Syndrome Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients